Overview

Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
This study will develop a national cord blood bank for siblings of patients with hemoglobinopathies and thalassemia.
Phase:
Phase 2
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Busulfan
Cyclophosphamide
Cyclosporine
Cyclosporins
Mycophenolate mofetil
Mycophenolic Acid